Nutraceuticals for metabolic syndrome management: from laboratory to benchside.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 23627983)

Published in Curr Vasc Pharmacol on January 01, 2014

Authors

Arrigo F Cicero, Elisa Tartagni, Sibel Ertek1

Author Affiliations

1: Sant'Orsola-Malpighi University Hospital, Padiglione 2, Via Albertoni 15, 40138 Bologna-Italy. arrigo.cicero@unibo.it.

Articles by these authors

25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch Med Sci (2012) 1.09

Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci (2013) 1.05

Metformin and its clinical use: new insights for an old drug in clinical practice. Arch Med Sci (2012) 0.96

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects. Hosp Pract (1995) (2012) 0.88

The older patient with hypertension: care and cure. Ther Adv Chronic Dis (2012) 0.81

Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence. Expert Opin Biol Ther (2014) 0.80

Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data. Expert Opin Drug Saf (2014) 0.80

Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers. Endocr Pathol (2012) 0.79

Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers. J Altern Complement Med (2013) 0.78

Dietary determinants of oxidized-low-density lipoprotein antibodies in a sample of pharmacologically untreated non-smoker subjects: data from the Brisighella heart study. Adv Clin Exp Med (2013) 0.77

Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin. Arch Med Res (2008) 0.77

Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital. J Cardiovasc Med (Hagerstown) (2013) 0.75